The global intraosseous devices market is valued at US$ 451 million as of 2022. The market is expected to grow at a CAGR of 5.8% during the period 2022-2032, and by 2032, the market is expected to reach a valuation of US$ 792.56 million.
| Attributes | Value |
|---|---|
| Intraosseous Devices Market Value (2022) | US$ 451 million |
| Intraosseous Devices Market Forecast Value (2032) | US$ 792.56 million |
| Intraosseous Devices Market Expected CAGR (2022 to 2032) | 5.8% |
Increasing demand for the rapid administration of fluids directly into the vascular system is the primary factor driving the demand for intraosseous devices. This has been significantly important, especially during times of emergency.
Furthermore, an increase in the number of disease forms is expected to surge the market. Moreover, the rising number of traumatic surgeries worldwide is expected to increase the sales of intraosseous devices during the forecast period.
Additionally, the development of technologically advanced intraosseous devices is expected to surge the market growth. These provide rapid and reliable emergency vascular access.
Apart from that, the companies that are into intraosseous devices are adding certain value-added services, which is also expected to further surge the market growth.
Patients are particularly impressed by the safety that is provided by this method, and this advantage is being provided at a time when no other method can come close to the safety aspects of this method.
Establishment of vascular access is required in case of medical emergency and life-threatening traumatic injuries for the delivery of medications and for fluid replacement, including crystalloids, blood, and blood products.
The potential use of this technique called as, intraosseous infusion was established in 1920’s as a rapid, safe and effective method of vascular access through the bone marrow when intravenous attempt fails to establish vascular access.
Historically intraosseous infusion (IO) was recommended only in children’s younger than six years whereas now use of IO techniques in patients of all ages is supported by guidelines for cardiopulmonary resuscitation.
Currently there are many intraosseous devices available in the market for the rapid administration of fluids and medications directly into the vascular systems. These devices are inserted directly into the medullary space of bone, and range from manually inserted spinal needles to the impact drivers and drill powered devices.
The manually inserted needles have been approved in the U.S. since 1940’s. In addition site of insertion also plays an important role in defining the overall approach in instraosseous infusion. Various sites available for intraosseous insertion includes sternum, distal and proximal tibia, distal femur and calcaneum. The device is quickly inserted and correct placement of the device is confirmed by the flow of intravenous fluid into the device.
If at all extravasation of the fluid around the insertion site occurs, the device is removed to prevent development of compartment syndrome. However aspiration of bone marrow represent another approach to confirm the correct placement of the device. One of the fastest and most reliable means of administrating the emergency fluids in the sternum is sternal intraosseous infusion (IO) allowing easy vascular access.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
An increase in the prevalence of emergency resuscitation, coupled with cardiac arrests, presents a massive scope for the market.
Moreover, the manufacturers are developing much more user-friendly forms of intraosseous devices, which might have a positive influence on the intraosseous device adoption trends.
One of the major restraints for the market remains the development of compartment syndrome.
Apart from that, the patients have also experienced iatrogenic fractures, growth plate injury, and osteomyelitis. This might challenge the market growth.
Principal Consultant
On the basis of type, the automatic segment is projected to have the largest market share. The ability to operate with maximum precision coupled with low operational time is expected to surge the share of the segment going ahead. Apart from that, the ability to penetrate the vascular system is more in the automatic segment as compared to other segments.
On the basis of end users, the hospitals segment has the largest share. Apart from that, hospitals are usually involved in the bulk purchase of these devices. Furthermore, hospitals need to be equipped with almost every kind of medical device, as a result of which they constantly fill in their stocks. Furthermore, an increasing geriatric population coupled with a surging number of heart patients also make hospitals the leading segment.
On the basis of region, the North American region has the highest market share. A huge healthcare sector in the region, coupled with a high disposable income, is expected to surge the market share.
Furthermore, the region is also meant for a huge number of people who suffer from heart-related ailments. This represents a huge opportunity for the intraosseous devices market in North America.
Apart from that, the European region is expected to be one of the most important markets during the forecast period.
Intraosseous infusion is primarily used in pre-hospital’s pediatric emergencies where intravenous delivery of fluids and medications is difficult. Increasing prevalence of various diseases forms and growing number of traumatic surgeries are expected to create demand for these devices in the forthcoming years.
Additionally introduction of technologically advanced intraosseous devices in the market such as EZ-IO which allows rapid and more reliable emergency vascular access than the available manual techniques in the market. Continual training of medical and nursing staff and well defined protocols regarding proper handling of the device required for effective and safe care of patients undergoing intraosseous venous access is also leading to the rising adoption of these devices in hospitals.
One of the main complication while inserting the intraosseous device is extravasation of fluids and medications into soft tissues which can lead to compartment syndrome (a condition resulting from increased pressure within a confined body space). Other side effects associated with the use of these devices includes iatrogenic fractures, growth plate injury, infection (cellulitis) and osteomyelitis.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
With rising number of traumatic events coupled with failure of intravenous vascular access is expected to fuel the demand for intraosseous devices in the near future. Intraosseous infusion is safe and effective technology in case of cardiopulmonary resuscitation where other route of administration fail to deliver the required effect.
Other vascular access procedures such as peripheral venous access is a time consuming procedure thus making it not feasible for cardiopulmonary resuscitation. The intraosseous devices market is expected to grow at a healthy pace over the forecasted period.
On the basis of region presence, intraosseous devices market is segmented into seven key regions: North America, Latin America, and Eastern Europe, Western Europe, and Asia pacific excluding japan, Japan, Middle East and Africa. North America and Europe are the biggest markets for the intraosseous device market.
Owing to rapid launch of various technologically advanced intraosseous devices by big manufacturers and increasing incidences of various cardiac disorders are some of the factors expected to pull the growth of these devices in the North American market. In addition macroeconomic factors such as FDA approvals are also expected to increase the adoption rate of such devices in the developed countries.
Also big players such as, Pyng Medical Corp., are entering the Asia pacific market by expanding its distribution network which is expected to create market opportunity for the intraosseous device market in Asia Pacific region.
Some of the key market players in the intraosseous devices market are Pyng Medical Corp., PerSys Medical, Aero Healthcare, Vidacare Corporation, Carefusion Inc., Cook Medical Inc.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.
It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Intraosseous Devices market is segmented on basis of technology, route of administration, end user and geography:
Explore Healthcare Insights
View Reports
Intraosseous Devices Market
